| Basics |
|
bioAffinity Technologies, Inc.
|
| IPO Date: |
September 1, 2022 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$7.33M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 5.14%
|
| Avg Daily Range (30 D): |
$0.08 | 4.32%
|
| Avg Daily Range (90 D): |
$0.12 | 5.41%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.64M |
| Avg Daily Volume (30 D): |
.1M |
| Avg Daily Volume (90 D): |
3.9M |
| Trade Size |
| Avg Trade Size (Sh.): |
297 |
| Avg Trade Size (Sh.) (30 D): |
187 |
| Avg Trade Size (Sh.) (90 D): |
225 |
| Institutional Trades |
| Total Inst.Trades: |
13 |
| Avg Inst. Trade: |
$1.29M |
| Avg Inst. Trade (30 D): |
$1.27M |
| Avg Inst. Trade (90 D): |
$1.27M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$10.53
|
$-4.74
|
$-.17
|
|
Diluted EPS
|
$7.92
|
$-4.74
|
$-.17
|
|
Revenue
|
$ 6.78M
|
$ 1.45M
|
$ 1.27M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -14.74M
|
$ -5.05M
|
$ -4.06M
|
|
Operating Income / Loss
|
$ -10.38M
|
$ -2.29M
|
$ -2.52M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 6.91M
|
$ 6.87M
|
$ .36M
|
|
PE Ratio
|
0.21
|
|
|
| Splits |
|
Sep 19, 2025:
1:30
|
|
|
|